Market Cap 1.99B
Revenue (ttm) 9.04M
Net Income (ttm) -292.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,240.71%
Debt to Equity Ratio 0.00
Volume 844,200
Avg Vol 1,975,890
Day's Range N/A - N/A
Shares Out 91.71M
Stochastic %K 54%
Beta 2.17
Analysts Strong Sell
Price Target $34.25

Company Profile

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 939 7410
Address:
18702 North Creek Parkway, Suite 100, Bothell, United States
economist9
economist9 Dec. 23 at 6:17 PM
$IMNM Post ph3 data Guggenheim $IMNM Buy; $35 Model updated post $400M equity financing Positive Phase 3 results, $IMNM plans to submit an NDA for varegacestat in 2Q26, representing a potl. best-in-class systemic therapy for desmoid tumors. Potential commercial launch of
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Dec. 22 at 2:45 PM
$IMNM CEO purchased 7,278 shares at $20.48 for a total of $149,053. SIEGALL CLAY B now owns 860,525 shares. https://ceo-buys.com
0 · Reply
Smellmahass
Smellmahass Dec. 21 at 11:19 PM
$IMNM Should be over 25 this week.
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 20 at 8:34 PM
How Radioisotopes Are Being Used to De-Risk Antibody-Drug Conjugate (ADC) Development $RADX $IMNM $MNPR $PYXS https://blog.championsoncology.com/blog/how-radiopharmaceuticals-are-being-used-to-de-risk-antibody-drug-conjugate-adc-development
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 7:06 PM
Market update - My 26 thoughts will come out in the week ahead. Let’s talk now. I believed a large cap bid would eventually save $QQQ and it did. This week could have some volatility as volume will be light. 600 & 580 are my rough levels to add risk. $NVDA has gone through many periods of underperformance only to shock and awe all over again. I expect a move back above the 50 day soon . One catalyst could be CES January 6th. In a market where there is less to invest in due to elevated valuations. I’m a big fan of home builders longer term. Yes they are ugly with broken charts, note the investment not trade wording. Will update you when I go long. I continue to love my $RKT. Biotech missed the entire bull market and will still play catch up. I think mergers & valuation help $XBI lead a bit longer. As always large gains often come from the stocks not the index. $IMNM was up over 400% from April lows this week as an example. Subscribe for access! It's free 👉 @StockAnalyst_SA
0 · Reply
SignalVampire7
SignalVampire7 Dec. 20 at 3:06 PM
$IMNM biotech with active tape, higher lows into next catalyst and breakout volume would confirm the rerate leg
0 · Reply
Smellmahass
Smellmahass Dec. 19 at 7:53 PM
$IMNM Good start. Next week could close 25.
0 · Reply
epictradesDP
epictradesDP Dec. 19 at 6:42 PM
$IMNM +8% continues to make new highs on day
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 19 at 4:54 PM
Some thoughts b4 I travel. I thought bids would come into large cap tech soon and they sure did. Today could be end of year and I'd be happy as a clam. $QQQ back above the 50 & 21 day. Bulls want to see it close above 613s. $IMNM patience paid off as we hit year highs 28 Monday. I sold quite a bit and started to add back 20 ish. $ORCL rally makes sense to me as it became a lazy short and was due a short term rally. Homebuilders looking bleak again and will be a focus for longer term port in days ahead. $NVDA still cheap and probably not gone rallying. Have a great weekend Subscribe for access! It's free 👉 @StockAnalyst_SA
0 · Reply
epictradesDP
epictradesDP Dec. 19 at 4:40 PM
Some thoughts b4 I travel. I thought bids would come into large cap tech soon and they sure did. Today could be end of year and I'd be happy as a clam. $QQQ back above the 50 & 21 day. Bulls want to see it close above 613s. $IMNM patience paid off as we hit year highs 28 Monday. I sold quite a bit and started to add back 20 ish. $ORCL rally makes sense to me as it became a lazy short and was due a short term rally. Homebuilders looking bleak again and will be a focus for longer term port in days ahead. $NVDA still cheap and probably not gone rallying. Have a great weekend
0 · Reply
Latest News on IMNM
Immunome Announces Pricing of Public Offering of Common Stock

Dec 16, 2025, 8:16 PM EST - 8 days ago

Immunome Announces Pricing of Public Offering of Common Stock


Immunome Announces Proposed Public Offering of Common Stock

Dec 15, 2025, 4:01 PM EST - 9 days ago

Immunome Announces Proposed Public Offering of Common Stock


Immunome to Present at Upcoming Investor Conferences

Nov 25, 2025, 8:00 AM EST - 4 weeks ago

Immunome to Present at Upcoming Investor Conferences


Infinimmune Announces Research Collaboration with Immunome

Sep 18, 2025, 8:00 AM EDT - 3 months ago

Infinimmune Announces Research Collaboration with Immunome


Immunome: SpringWorks Buyout Informs The Potential Upside Here

Aug 11, 2025, 10:31 PM EDT - 4 months ago

Immunome: SpringWorks Buyout Informs The Potential Upside Here


Immunome: Transformed Pipeline Offers Multiple Catalysts

Apr 17, 2025, 6:06 AM EDT - 8 months ago

Immunome: Transformed Pipeline Offers Multiple Catalysts


Immunome to Present at Upcoming March Conferences

Feb 25, 2025, 8:00 AM EST - 10 months ago

Immunome to Present at Upcoming March Conferences


Immunome Can Take The Fight To Competitors With Varegacestat

Jan 30, 2025, 10:27 AM EST - 11 months ago

Immunome Can Take The Fight To Competitors With Varegacestat


Immunome Appoints Phil Tsai as Chief Technical Officer

Jun 27, 2024, 8:00 AM EDT - 1 year ago

Immunome Appoints Phil Tsai as Chief Technical Officer


Immunome Appoints Kinney Horn as Chief Business Officer

May 2, 2024, 8:00 AM EDT - 1 year ago

Immunome Appoints Kinney Horn as Chief Business Officer


Immunome Appoints Sandra M. Swain to Board of Directors

Apr 25, 2024, 8:26 AM EDT - 1 year ago

Immunome Appoints Sandra M. Swain to Board of Directors


Immunome: An Oncology Powerhouse In The Making

Apr 2, 2024, 2:07 PM EDT - 1 year ago

Immunome: An Oncology Powerhouse In The Making


economist9
economist9 Dec. 23 at 6:17 PM
$IMNM Post ph3 data Guggenheim $IMNM Buy; $35 Model updated post $400M equity financing Positive Phase 3 results, $IMNM plans to submit an NDA for varegacestat in 2Q26, representing a potl. best-in-class systemic therapy for desmoid tumors. Potential commercial launch of
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Dec. 22 at 2:45 PM
$IMNM CEO purchased 7,278 shares at $20.48 for a total of $149,053. SIEGALL CLAY B now owns 860,525 shares. https://ceo-buys.com
0 · Reply
Smellmahass
Smellmahass Dec. 21 at 11:19 PM
$IMNM Should be over 25 this week.
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 20 at 8:34 PM
How Radioisotopes Are Being Used to De-Risk Antibody-Drug Conjugate (ADC) Development $RADX $IMNM $MNPR $PYXS https://blog.championsoncology.com/blog/how-radiopharmaceuticals-are-being-used-to-de-risk-antibody-drug-conjugate-adc-development
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 7:06 PM
Market update - My 26 thoughts will come out in the week ahead. Let’s talk now. I believed a large cap bid would eventually save $QQQ and it did. This week could have some volatility as volume will be light. 600 & 580 are my rough levels to add risk. $NVDA has gone through many periods of underperformance only to shock and awe all over again. I expect a move back above the 50 day soon . One catalyst could be CES January 6th. In a market where there is less to invest in due to elevated valuations. I’m a big fan of home builders longer term. Yes they are ugly with broken charts, note the investment not trade wording. Will update you when I go long. I continue to love my $RKT. Biotech missed the entire bull market and will still play catch up. I think mergers & valuation help $XBI lead a bit longer. As always large gains often come from the stocks not the index. $IMNM was up over 400% from April lows this week as an example. Subscribe for access! It's free 👉 @StockAnalyst_SA
0 · Reply
SignalVampire7
SignalVampire7 Dec. 20 at 3:06 PM
$IMNM biotech with active tape, higher lows into next catalyst and breakout volume would confirm the rerate leg
0 · Reply
Smellmahass
Smellmahass Dec. 19 at 7:53 PM
$IMNM Good start. Next week could close 25.
0 · Reply
epictradesDP
epictradesDP Dec. 19 at 6:42 PM
$IMNM +8% continues to make new highs on day
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 19 at 4:54 PM
Some thoughts b4 I travel. I thought bids would come into large cap tech soon and they sure did. Today could be end of year and I'd be happy as a clam. $QQQ back above the 50 & 21 day. Bulls want to see it close above 613s. $IMNM patience paid off as we hit year highs 28 Monday. I sold quite a bit and started to add back 20 ish. $ORCL rally makes sense to me as it became a lazy short and was due a short term rally. Homebuilders looking bleak again and will be a focus for longer term port in days ahead. $NVDA still cheap and probably not gone rallying. Have a great weekend Subscribe for access! It's free 👉 @StockAnalyst_SA
0 · Reply
epictradesDP
epictradesDP Dec. 19 at 4:40 PM
Some thoughts b4 I travel. I thought bids would come into large cap tech soon and they sure did. Today could be end of year and I'd be happy as a clam. $QQQ back above the 50 & 21 day. Bulls want to see it close above 613s. $IMNM patience paid off as we hit year highs 28 Monday. I sold quite a bit and started to add back 20 ish. $ORCL rally makes sense to me as it became a lazy short and was due a short term rally. Homebuilders looking bleak again and will be a focus for longer term port in days ahead. $NVDA still cheap and probably not gone rallying. Have a great weekend
0 · Reply
Smellmahass
Smellmahass Dec. 19 at 4:10 PM
$IMNM I want to buy more but no more money. I think this is tutes buying.
0 · Reply
epictradesDP
epictradesDP Dec. 19 at 4:07 PM
$IMNM +5%
0 · Reply
yellowtweet
yellowtweet Dec. 19 at 3:12 PM
$BEAT $IMNM $SMX 2nd globally. Nice $BEAT
0 · Reply
marione
marione Dec. 19 at 2:50 PM
$BEAT $SMX $IMNM LOS ANGELES, CA – December 18, 2025 (NEWMEDIAWIRE) – HeartBeam (NASDAQ: BEAT), a medical technology company developing advanced electrocardiogram solutions, was recently featured in a news article discussing its recognition as a Global IP and Technology Leader in Wearable Cardiac Diagnostics by PatentVest's "Total Cardiac Intelligence" report. "The company ranked second globally in 12-lead ECG innovation among 243 companies analyzed, behind only GE Healthcare. This recognition highlights HeartBeam's growing influence in the next generation of cardiac monitoring technologies," the article reads. HeartBeam's ranking underscores the rapid maturation of the company's proprietary ECG synthesis system, which captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a 12-lead ECG. This unique approach enables physicians to obtain cardiologist-grade ECG data from compact devices that can be used by patients or clinicians away
0 · Reply
dividendmaker
dividendmaker Dec. 19 at 1:49 PM
$IMNM ceo put a million of his own money into the round that’s awesome
1 · Reply
flam70
flam70 Dec. 19 at 1:48 PM
$IMNM JPM Note - We caught up with IMNM’s mgmt following the company's call and top-line results (see our first take ). We wanted to pass along the key highlights from our discussion below. In our DCF-based model, we are updating our assumptions following the topline ( more below ). Reflecting the changes, we arrive at our new Dec-2026 PT of $32.X (previously $22). Reiterate OW on IMNM.
0 · Reply
Smellmahass
Smellmahass Dec. 19 at 11:40 AM
$IMNM All the bullish sign.
0 · Reply
InItToWinIt100
InItToWinIt100 Dec. 19 at 8:36 AM
$IMNM Approaching $27 recent highs from back in March. Massive volume on the weekly candle. Keep an eye on this one! go.trade-ideas.com/SH16z
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Dec. 19 at 12:10 AM
$IMNM CEO purchased 46,511 shares at $21.50 for a total of $999,987. SIEGALL CLAY B now owns 853,247 shares. https://ceo-buys.com
0 · Reply
Apes_Strong
Apes_Strong Dec. 18 at 10:34 PM
$IMNM yes he did
1 · Reply
Smellmahass
Smellmahass Dec. 18 at 10:18 PM
$IMNM CEO bought common shares.
0 · Reply
lenten
lenten Dec. 18 at 9:40 PM
0 · Reply